|Articles|June 29, 2016
Manufacturing Controlled Substances
Advertisement
David Mayers, president of Wellspring Pharma Services sat down with Pharmaceutical Technology to discuss the manufacture of controlled substances.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
3
Shaping the Future of Microbial Development: From Gene to GMP
4
The Role of Standards in Sustainability
5